CONFRONTING B IOLOGICAL W EAPONS INVITED A RTICLE

[1]  M. Enserink.  Smallpox Vaccines: Looking Beyond the Next Generation , 2004, Science.

[2]  S. Walter,et al.  SARS among Critical Care Nurses, Toronto , 2004, Emerging infectious diseases.

[3]  G. Poland,et al.  Smallpox vaccine: problems and prospects. , 2003, Immunology and allergy clinics of North America.

[4]  S. Hansen,et al.  Duration of antiviral immunity after smallpox vaccination , 2003, Nature Medicine.

[5]  W. Bicknell,et al.  Smallpox vaccination after a bioterrorism-based exposure. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[6]  W. Casscells,et al.  Influenza as a bioweapon. , 2003, Journal of the Royal Society of Medicine.

[7]  S. Ostroff,et al.  Myopericarditis following smallpox vaccination among vaccinia-naive US military personnel. , 2003, JAMA.

[8]  W. Winkenwerder,et al.  US military smallpox vaccination program experience. , 2003, JAMA.

[9]  D. Milton.  Smallpox and smallpox vaccination. , 2003, The New England journal of medicine.

[10]  J. Peiris,et al.  Effectiveness of precautions against droplets and contact in prevention of nosocomial transmission of severe acute respiratory syndrome (SARS) , 2003, The Lancet.

[11]  J. Goldstein,et al.  Evaluation of 21st-Century Risks of Smallpox Vaccination and Policy Options , 2003, Annals of Internal Medicine.

[12]  P. Mortimer.  Can postexposure vaccination against smallpox succeed? , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[13]  Thomas Mack,et al.  A different view of smallpox and vaccination. , 2003, The New England journal of medicine.

[14]  Sally C Morton,et al.  A model for a smallpox-vaccination policy. , 2003, The New England journal of medicine.

[15]  E. Kern,et al.  In vitro activity of potential anti-poxvirus agents , 2003, Antiviral research.

[16]  H. Pennington.  Smallpox and bioterrorism. , 2003, Bulletin of the World Health Organization.

[17]  Martin Enserink,et al.  Rough-and-Tumble Behind Bush's Smallpox Policy , 2002, Science.

[18]  S. Block.  A Not-So-Cheap Stunt , 2002, Science.

[19]  Jennifer Couzin,et al.  Active Poliovirus Baked From Scratch , 2002, Science.

[20]  E. Clercq.  Cidofovir in the treatment of poxvirus infections , 2002 .

[21]  G. McFadden,et al.  Smallpox: anything to declare? , 2002, Nature Reviews Immunology.

[22]  K. Morris.  Oral drug and old vaccine renew smallpox bioterror debate. , 2002, The Lancet. Infectious diseases.

[23]  William J Bicknell,et al.  The case for voluntary smallpox vaccination. , 2002, The New England journal of medicine.

[24]  D A Henderson,et al.  Diagnosis and management of smallpox. , 2002, The New England journal of medicine.

[25]  A. Kemper,et al.  Expected adverse events in a mass smallpox vaccination campaign. , 2002, Effective clinical practice : ECP.

[26]  Richard Preston,et al.  The Demon in the Freezer , 2002 .

[27]  Steve Leach,et al.  Transmission potential of smallpox in contemporary populations , 2001, Nature.

[28]  A. Ramsay,et al.  Expression of Mouse Interleukin-4 by a Recombinant Ectromelia Virus Suppresses Cytolytic Lymphocyte Responses and Overcomes Genetic Resistance to Mousepox , 2001, Journal of Virology.

[29]  D. Smee,et al.  Cidofovir protects mice against lethal aerosol or intranasal cowpox virus challenge. , 2000, The Journal of infectious diseases.

[30]  Philip K. Russell,et al.  Smallpox as a biological weapon: medical and public health management. Working Group on Civilian Biodefense. , 1999, JAMA.

[31]  D A Henderson,et al.  The looming threat of bioterrorism. , 1999, Science.

[32]  F. Fenner.  Smallpox and its eradication , 1988 .

[33]  A. Sommer.  The 1972 smallpox outbreak in Khulna Municipality, Bangladesh. II. Effectiveness of surveillance and containment in urban epidemic control. , 1974, American journal of epidemiology.

[34]  T. Mack,et al.  Smallpox in Europe, 1950-1971. , 1972, The Journal of infectious diseases.

[35]  R. Anthony,et al.  Field trials of methisazone as a prophylactic agent against smallpox. , 1971, American journal of epidemiology.

[36]  H. Gelfand,et al.  The recent outbreak of smallpox in Meschede, West Germany. , 1971, American journal of epidemiology.

[37]  N. Hahon,et al.  Assessment of aerosol mixtures of different viruses. , 1970, Applied microbiology.

[38]  P. A. Young,et al.  Prophylaxis of smallpox with methisazone. , 1969, American journal of epidemiology.

[39]  C. Lerche,et al.  [Smallpox in Europe]. , 1967, Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke.

[40]  L. Proença,et al.  Methisazone in prevention of variola minor among contacts. , 1965, Lancet.

[41]  A. Downie,et al.  The recovery of smallpox virus from patients and their environment in a smallpox hospital. , 1965, Bulletin of the World Health Organization.